Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab
Go back to Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1160.24 +0.16 (0.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.08 | 52 Week High | $88.16 | |||
| Open | $1170.00 | 52 Week Low | $67.88 | |||
| Day High | $1171.66 | P/E | 268.57 | |||
| Day Low | $1137.50 | EPS | $4.32 | |||
| Volume | 950,284 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.82 -0.2 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.02 | 52 Week High | $37.39 | |||
| Open | $29.09 | 52 Week Low | $28.25 | |||
| Day High | $29.21 | P/E | 17.47 | |||
| Day Low | $28.44 | EPS | $1.65 | |||
| Volume | 14,570,611 | |||||
